Abstract # 2237 Maturing Toxicity and Outcomes of a Phase I Trial of Concurrent, Daily Gefitinib and Radiation or Chemoradiation for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LASCCHN)

Presenter: Raben, D

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results

> Conclusions

> View tables/images/videos


Authors:
Raben, D (1) ; Chen, Changhu (1) ; Eckhardt, G S (1) ; Kane, M (1) ; Song, J I (1) ; Bemis, L (1) ; Varella-Garcia , M (1) ; Brualdi, L (1) ; Raben, A (1) ; Hu, K (1) ; Quon, H (1) ; Dancey, J (1) .

Institutions:
1. Radiation Oncology, University of Colorado, Aurora, CO, USA.

E-mail a friend about this abstract:
Enter email address:   





Abstracts main page


Logout